NCT05597163View on ClinicalTrials.gov

Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents

NANot yet recruitingINTERVENTIONAL
Enrollment

588

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2025

Conditions
Myopia, Progressive
Interventions
DRUG

low concentration atropine (0.01%)

0.01% atropine eye drop

DRUG

low concentration atropine (0.025%)

0.025% atropine eye drop

DRUG

low concentration atropine (0.05%)

0.05% atropine eye drop

DRUG

Placebo

Placebo eye drop

All Listed Sponsors
collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Peking University People's Hospital

OTHER

collaborator

Shandong University of Traditional Chinese Medicine

OTHER

lead

Shanghai Eye Disease Prevention and Treatment Center

OTHER

NCT05597163 - Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents | Biotech Hunter | Biotech Hunter